Home / Research library / Noopept Powder
Noopept Powder: molecular data, studies & sources
Noopept Powder is catalogued here as a research compound. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.
Compiled by PeptideTech Editors · Sources checked · Selected bibliography, not a systematic review
Molecular formula, weight & structure
- Molecular formula (MF)
- C17H22N2O4
- Molecular weight (MW)
- 318.4 g/mol
- PubChem compound ID
- 180496
- Record title
- 1-(2-Phenylacetyl)-L-prolylglycine ethy ester
Values describe the selected PubChem molecular entity. Counterions, salt forms, hydration and sequence changes can alter the supplied material. Confirm the exact identity against the supplier specification.
Source: PubChem CID 180496 · retrieved 2026-09-21

Chemical identifiers and source data
- IUPAC name
- ethyl 2-[[(2S)-1-(2-phenylacetyl)pyrrolidine-2-carbonyl]amino]acetate
- InChIKey
- PJNSMUBMSNAEEN-AWEZNQCLSA-N
- SMILES
- CCOC(=O)CNC(=O)[C@@H]1CCCN1C(=O)CC2=CC=CC=C2
Human and clinical studies
Selected human-study records are shown with their indexed or reviewed study type. Check the original article for the intervention, formulation and controls; the molecule can also be a comparator or measured variable.
- Human study · PubMed trial index
[Clinical and electroencephalographic characteristic of noopept in patients with mild cognitive impairment of posttraumatic and vascular origin].
Bochkarev VK, Teleshova ES, Siuniakov SA et al. · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2008
PMID 19008801
- Human study · PubMed trial index
[Noopept in the treatment of mild cognitive impairment in patients with stroke].
Amelin AV, Iliukhina AIu, Shmonin AA et al. · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2011
PMID 22500312
Preclinical research, reviews & other publications
Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.
- Preclinical / laboratory research
Effects of noopept on cognitive functions and pubertal process in rats with diabetes.
Gürbüz P, Düzova H, Yildiz A et al. · Life sciences · 2019
PMID 31356906 · DOI: 10.1016/j.lfs.2019.116698
- Review · secondary evidence
[The original novel nootropic and neuroprotective agent noopept].
Ostrovskaia RU, Gudasheva TA, Voronina TA et al. · Eksperimental'naia i klinicheskaia farmakologiia · 2002
PMID 12596521
- Research publication · design requires review
Cognitive Enhancer Noopept Activates Transcription Factor HIF-1.
Zainullina LF, Ivanova TV, Sadovnikov SV et al. · Doklady. Biochemistry and biophysics · 2020
PMID 33119829 · DOI: 10.1134/S1607672920050129
- Preclinical / laboratory research
Noopept normalizes parameters of the incretin system in rats with experimental diabetes.
Ostrovskaya RU, Zolotov NN, Ozerova IV et al. · Bulletin of experimental biology and medicine · 2014
PMID 25065315 · DOI: 10.1007/s10517-014-2562-5
Noopept Powder supplier sources
Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.
Compare all Noopept Powder sizes, forms and supplier prices →
| Supplier | Recorded packages | Example source listing |
|---|---|---|
| Amino USAUSD | 10000mg Powder1 recorded offers | 10000mg Powder · $18.00Checked Sep 16, 2026Supplier listing |
Reference sources & further reading
- PubChem compound record 180496 — chemical identity and structure.
- Wikipedia: Omberacetam — Background encyclopedia; not a primary clinical source.
The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.
Search for additional research
These links run searches; their results have not been individually reviewed and can include unrelated compounds.
Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.
Related research profiles
Adalank Spray
Molecular identity needs further verification
Source verification pending
0 selected publications · 0 human study records
Adamax
Molecular identity needs further verification
Source verification pending
0 selected publications · 0 human study records
Agomelatine Powder
C15H17NO2
243.30 g/mol · PubChem CID 82148
8 selected publications · 5 human study records
Cerebrolysin
Molecular identity needs further verification
7 selected publications · 5 human study records
Dihexa
C27H44N4O5
504.7 g/mol · PubChem CID 129010512
0 selected publications · 0 human study records
Fasoracetam Powder
C10H16N2O2
196.25 g/mol · PubChem CID 198695
3 selected publications · 1 human study records